TY - JOUR
T1 - Prospects on coupling UV/H2O2 with activated sludge or a fungal treatment for the removal of pharmaceutically active compounds in real hospital wastewater
AU - Mir-Tutusaus, Josep Anton
AU - Jaén-Gil, Adrián
AU - Barceló, Damià
AU - Buttiglieri, Gianluigi
AU - Gonzalez-Olmos, Rafael
AU - Rodriguez-Mozaz, Sara
AU - Caminal, Glòria
AU - Sarrà, Montserrat
N1 - Funding Information:
This work has been funded by the Spanish Ministry of Economy and Competitiveness (project CTM 2013-48545-C2-1-R) and partly supported by the Generalitat de Catalunya (Consolidated Research Groups 2017-SGR-0014, 2017 SGR 1124 and 2017-SGR1404). J. A. Mir-Tutusaus acknowledges the predoctoral grant from UAB. S. Rodriguez-Mozaz and R. Gonzalez-Olmos acknowledge the “Redes de Excelencia 2015” program (CTM2015-71054-REDT). S. Rodriguez-Mozaz and G. Buttiglieri acknowledge the Ramon y Cajal research fellowships (RYC-2014- 16707 and RYC-2014-16754) as well as CLEaN-TOUR (CTM2017-85385-C2-1-R), from the Spanish Ministry of Economy and Competitiveness. Adrián Jaén-Gil acknowledges the predoctoral grant 2019FI_B2_00202 from AGAUR and co-financed by the European Social Fund. ICRA researchers thank funding from CERCA program. We would like to thank Sant Joan de Déu Hospital staff for their collaboration during the sampling campaign and Aleix Benito for his support in the laboratory with the UV/H2O2 experiments.
Funding Information:
This work has been funded by the Spanish Ministry of Economy and Competitiveness (project CTM 2013-48545-C2-1-R ) and partly supported by the Generalitat de Catalunya (Consolidated Research Groups 2017-SGR-0014 , 2017 SGR 1124 and 2017-SGR1404 ). J. A. Mir-Tutusaus acknowledges the predoctoral grant from UAB. S. Rodriguez-Mozaz and R. Gonzalez-Olmos acknowledge the “Redes de Excelencia 2015” program (CTM2015-71054-REDT). S. Rodriguez-Mozaz and G. Buttiglieri acknowledge the Ramon y Cajal research fellowships (RYC-2014- 16707 and RYC-2014-16754) as well as CLEaN-TOUR (CTM2017-85385-C2-1-R), from the Spanish Ministry of Economy and Competitiveness. Adrián Jaén-Gil acknowledges the predoctoral grant 2019FI_B2_00202 from AGAUR and co-financed by the European Social Fund . ICRA researchers thank funding from CERCA program. We would like to thank Sant Joan de Déu Hospital staff for their collaboration during the sampling campaign and Aleix Benito for his support in the laboratory with the UV/H 2 O 2 experiments.
Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2021/6/15
Y1 - 2021/6/15
N2 - Conventional active sludge (AS) process at municipal centralized wastewater treatment facilities may exhibit little pharmaceuticals (PhACs) removal efficiencies when treating hospital wastewater (HWW). Therefore, a dedicated efficient wastewater treatment at the source point is recommended. In this sense, advanced oxidation processes (AOPs) and fungal treatment (FG) have evidenced promising results in degrading PhACs. The coupling of the AOP based on UV/H2O2 treatment with biological treatment (AS or FG) treating a real non-sterile HWW, was evaluated in this work. In addition, a coagulation-flocculation pretreatment was applied to improve the efficiency of all approaches. Twenty-two PhACs were detected in raw HWW, which were effectively removed (93–95%) with the combination of any of the biological treatment followed by UV/H2O2 treatment. Similar removal results (94%) were obtained when placing UV/H2O2 treatment before FG, while a lower removal (83%) was obtained in the combination of UV/H2O2 followed by AS. However, the latest was the only treatment combination that achieved a decrease in the toxicity of water. Moreover, deconjugation of conjugated PhACs has been suggested for ofloxacin and lorazepam after AS treatment, and for ketoprofen after fungal treatment. Monitoring of carbamazepine and its transformation products along the treatment allowed to identify the same carbamazepine degradation pathway in UV/H2O2 and AS treatments, unlike fungal treatment, which followed another degradation route.
AB - Conventional active sludge (AS) process at municipal centralized wastewater treatment facilities may exhibit little pharmaceuticals (PhACs) removal efficiencies when treating hospital wastewater (HWW). Therefore, a dedicated efficient wastewater treatment at the source point is recommended. In this sense, advanced oxidation processes (AOPs) and fungal treatment (FG) have evidenced promising results in degrading PhACs. The coupling of the AOP based on UV/H2O2 treatment with biological treatment (AS or FG) treating a real non-sterile HWW, was evaluated in this work. In addition, a coagulation-flocculation pretreatment was applied to improve the efficiency of all approaches. Twenty-two PhACs were detected in raw HWW, which were effectively removed (93–95%) with the combination of any of the biological treatment followed by UV/H2O2 treatment. Similar removal results (94%) were obtained when placing UV/H2O2 treatment before FG, while a lower removal (83%) was obtained in the combination of UV/H2O2 followed by AS. However, the latest was the only treatment combination that achieved a decrease in the toxicity of water. Moreover, deconjugation of conjugated PhACs has been suggested for ofloxacin and lorazepam after AS treatment, and for ketoprofen after fungal treatment. Monitoring of carbamazepine and its transformation products along the treatment allowed to identify the same carbamazepine degradation pathway in UV/H2O2 and AS treatments, unlike fungal treatment, which followed another degradation route.
KW - AOP
KW - Activated sludge
KW - Decentralized treatment
KW - Fungal treatment
KW - Hospital wastewater
KW - UV/HO
UR - http://www.scopus.com/inward/record.url?scp=85100781842&partnerID=8YFLogxK
U2 - 10.1016/j.scitotenv.2021.145374
DO - 10.1016/j.scitotenv.2021.145374
M3 - Article
C2 - 33582328
AN - SCOPUS:85100781842
SN - 0048-9697
VL - 773
JO - Science of the Total Environment
JF - Science of the Total Environment
M1 - 145374
ER -